PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $126,000 | -48.8% | 48,961 | -50.3% | 0.00% | – |
| Q4 2020 | $246,000 | -3.1% | 98,530 | -19.8% | 0.00% | – |
| Q3 2020 | $254,000 | -53.5% | 122,914 | -30.3% | 0.00% | -100.0% |
| Q2 2020 | $546,000 | +32.5% | 176,266 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $412,000 | +564.5% | 180,766 | +956.9% | 0.00% | – |
| Q4 2019 | $62,000 | -62.9% | 17,103 | -51.9% | 0.00% | – |
| Q2 2019 | $167,000 | +13.6% | 35,578 | -19.0% | 0.00% | – |
| Q1 2019 | $147,000 | -58.2% | 43,914 | -66.8% | 0.00% | – |
| Q4 2018 | $352,000 | -54.6% | 132,335 | -4.4% | 0.00% | -100.0% |
| Q3 2018 | $775,000 | -24.6% | 138,464 | -31.7% | 0.00% | 0.0% |
| Q2 2018 | $1,028,000 | -63.7% | 202,743 | -51.2% | 0.00% | -66.7% |
| Q1 2018 | $2,835,000 | +53.2% | 415,736 | +69.5% | 0.00% | +50.0% |
| Q4 2017 | $1,851,000 | +343.9% | 245,217 | +238.4% | 0.00% | – |
| Q3 2017 | $417,000 | – | 72,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |